What Matters Most: Case Study of Successful Patient-Directed Gabapentin Taper to Improve Mentation, Mobility, and Medications

Affiliations

¹ Geriatric Research Education and Clinical Center (GRECC), VA Puget Sound Medical Center, Seattle, Washington, USA.
² Division of Geriatrics and Gerontology, Department of Medicine, University of Washington, Seattle, Washington, USA.
³ Academic Detailing Program, Clinical Pharmacy Services, Veterans Integrated Services Network (VISN) 20, Vancouver, Washington, USA.
⁴ Clinical Pharmacy, Optum Care Washington DBA the Polycinic PLLC, Everett, Washington, USA.

Michelle R Paulsen et al. J Am Geriatr Soc. 2025 Jun.

. 2025 Jun;73(6):1985-1988.

doi: 10.1111/jgs.19482. Epub 2025 Apr 24.

¹ Geriatric Research Education and Clinical Center (GRECC), VA Puget Sound Medical Center, Seattle, Washington, USA.
² Division of Geriatrics and Gerontology, Department of Medicine, University of Washington, Seattle, Washington, USA.
³ Academic Detailing Program, Clinical Pharmacy Services, Veterans Integrated Services Network (VISN) 20, Vancouver, Washington, USA.
⁴ Clinical Pharmacy, Optum Care Washington DBA the Polycinic PLLC, Everett, Washington, USA.

No abstract available

References

1. T. Yamashita, K. Takahashi, K. Yonenobu, and S. Kikuchi, “Prevalence of Neuropathic Pain in Cases With Chronic Pain Related to Spinal Disorders,” Journal of Orthopaedic Science 19, no. 1 (2014): 15–21.
1. M. E. Tinetti, A. D. Naik, L. Dindo, et al., “Association of Patient Priorities‐Aligned Decision‐Making With Patient Outcomes and Ambulatory Health Care Burden Among Older Adults With Multiple Chronic Conditions: A Nonrandomized Clinical Trial,” JAMA Internal Medicine 179, no. 12 (2019): 1688–1697, https://doi.org/10.1001/jamainternmed.2019.4235.
1. P. J. Wiffen, S. Derry, R. F. Bell, et al., “Gabapentin for Chronic Neuropathic Pain in Adults,” Cochrane Database of Systematic Reviews 6, no. 6 (2017): CD007938, https://doi.org/10.1002/14651858.CD007938.pub4.
1. R. Price, D. Smith, G. Franklin, et al., “Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary: Report of the AAN Guideline Subcommittee,” Neurology 98, no. 1 (2022): 31–43.
1. K. T. Tran, D. Hranicky, T. Lark, and N. Jacob, “Gabapentin Withdrawal Syndrome in the Presence of a Taper,” Bipolar Disorders 7, no. 3 (2005): 302–304.